Literature DB >> 12464665

Fatal attraction: chemokines and type 1 diabetes.

Mark A Atkinson1, S Brian Wilson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12464665      PMCID： PMC151644          DOI： 10.1172/JCI17311

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  19 in total

1.  Reflections on chemokines.

Authors:  M Baggiolini
Journal:  Immunol Rev       Date:  2000-10       Impact factor: 12.988

Review 2.  International union of pharmacology. XXII. Nomenclature for chemokine receptors.

Authors:  P M Murphy; M Baggiolini; I F Charo; C A Hébert; R Horuk; K Matsushima; L H Miller; J J Oppenheim; C A Power
Journal:  Pharmacol Rev       Date:  2000-03       Impact factor: 25.468

Review 3.  The biology of chemokines and their receptors.

Authors:  D Rossi; A Zlotnik
Journal:  Annu Rev Immunol       Date:  2000       Impact factor: 28.527

Review 4.  Chemokine signaling and functional responses: the role of receptor dimerization and TK pathway activation.

Authors:  M Mellado; J M Rodríguez-Frade; S Mañes; C Martínez-A
Journal:  Annu Rev Immunol       Date:  2001       Impact factor: 28.527

5.  Congenic mapping of the diabetogenic locus Idd4 to a 5.2-cM region of chromosome 11 in NOD mice: identification of two potential candidate subloci.

Authors:  Marsha Grattan; Qing-Sheng Mi; Craig Meagher; Terry L Delovitch
Journal:  Diabetes       Date:  2002-01       Impact factor: 9.461

6.  Differential expression of CC chemokines and the CCR5 receptor in the pancreas is associated with progression to type I diabetes.

Authors:  M J Cameron; G A Arreaza; M Grattan; C Meagher; S Sharif; M D Burdick; R M Strieter; D N Cook; T L Delovitch
Journal:  J Immunol       Date:  2000-07-15       Impact factor: 5.422

Review 7.  Type 1 diabetes: new perspectives on disease pathogenesis and treatment.

Authors:  M A Atkinson; G S Eisenbarth
Journal:  Lancet       Date:  2001-07-21       Impact factor: 79.321

8.  Monocyte chemoattractant protein-1 is expressed in pancreatic islets from prediabetic NOD mice and in interleukin-1 beta-exposed human and rat islet cells.

Authors:  M C Chen; P Proost; C Gysemans; C Mathieu; D L Eizirik
Journal:  Diabetologia       Date:  2001-03       Impact factor: 10.122

9.  Chemokine receptor CCR2 and CCR5 polymorphisms in children with insulin-dependent diabetes mellitus.

Authors:  C Szalai; A Császár; A Czinner; T Szabó; P Pánczél; L Madácsy; A Falus
Journal:  Pediatr Res       Date:  1999-07       Impact factor: 3.756

10.  Elevated serum IP-10 levels observed in type 1 diabetes.

Authors:  A Shimada; J Morimoto; K Kodama; R Suzuki; Y Oikawa; O Funae; A Kasuga; T Saruta; S Narumi
Journal:  Diabetes Care       Date:  2001-03       Impact factor: 19.112
View more
  9 in total

Review 1.  Immune cell trafficking to the islets during type 1 diabetes.

Authors:  A M Sandor; J Jacobelli; R S Friedman
Journal:  Clin Exp Immunol       Date:  2019-08-30       Impact factor: 4.330

2.  Immunohistochemical study of monocyte chemoattractant protein-1 in the pancreas of NOD mice following cyclophosphamide administration and during spontaneous diabetes.

Authors:  Yan Bai; Elizabeth Robinson; Ryan Chai; Jacqueline M Ross; Shiva Reddy
Journal:  J Mol Histol       Date:  2006-07-29       Impact factor: 2.611

3.  Expression of interferon inducible protein-10 in pancreas of mice.

Authors:  Dong Li; Su-Wen Zhu; Dong-Juan Liu; Guo-Liang Liu
Journal:  World J Gastroenterol       Date:  2005-08-14       Impact factor: 5.742

4.  Nonviral delivery of small interfering RNA into pancreas-associated immune cells prevents autoimmune diabetes.

Authors:  Wilhem Leconet; Pierre Petit; Sylvie Peraldi-Roux; Damien Bresson
Journal:  Mol Ther       Date:  2012-09-18       Impact factor: 11.454

5.  Dendritic cells in islets of Langerhans constitutively present beta cell-derived peptides bound to their class II MHC molecules.

Authors:  Boris Calderon; Anish Suri; Mark J Miller; Emil R Unanue
Journal:  Proc Natl Acad Sci U S A       Date:  2008-04-21       Impact factor: 11.205

6.  Combined phytochemistry and chemotaxis assays for identification and mechanistic analysis of anti-inflammatory phytochemicals in Fallopia japonica.

Authors:  Ming-Yi Shen; Yan-Jun Liu; Ming-Jaw Don; Hsien-Yueh Liu; Zeng-Weng Chen; Clément Mettling; Pierre Corbeau; Chih-Kang Chiang; Yu-Song Jang; Tzu-Hsuan Li; Paul Young; Cicero L T Chang; Yea-Lih Lin; Wen-Chin Yang
Journal:  PLoS One       Date:  2011-11-08       Impact factor: 3.240

7.  Catenarin Prevents Type 1 Diabetes in Nonobese Diabetic Mice via Inhibition of Leukocyte Migration Involving the MEK6/p38 and MEK7/JNK Pathways.

Authors:  Ming-Yi Shen; Yu-Ping Lin; Bei-Chang Yang; Yu-Song Jang; Chih-Kang Chiang; Clément Mettling; Zeng-Weng Chen; Joen-Rong Sheu; Cicero L Chang; Yea-Lih Lin; Wen-Chin Yang
Journal:  Evid Based Complement Alternat Med       Date:  2012-02-13       Impact factor: 2.629

8.  The novel therapeutic effect of phosphoinositide 3-kinase-γ inhibitor AS605240 in autoimmune diabetes.

Authors:  Jamil Azzi; Robert F Moore; Wassim Elyaman; Marwan Mounayar; Najib El Haddad; Sunmi Yang; Mollie Jurewicz; Ayumi Takakura; Alessandra Petrelli; Paolo Fiorina; Thomas Ruckle; Reza Abdi
Journal:  Diabetes       Date:  2012-03-08       Impact factor: 9.461

Review 9.  Naturally occurring anthraquinones: chemistry and therapeutic potential in autoimmune diabetes.

Authors:  Shih-Chang Chien; Yueh-Chen Wu; Zeng-Weng Chen; Wen-Chin Yang
Journal:  Evid Based Complement Alternat Med       Date:  2015-03-18       Impact factor: 2.629
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.